Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death.

Accumulating data suggest a link between alterations/deficiencies in cytoskeletal proteins and the progression of cardiomyopathy and heart failure, although the molecular basis for this link remains unclear. Cypher/ZASP is a cytoskeletal protein localized in the sarcomeric Z-line. Mutations in its encoding gene have been identified in patients with isolated non-compaction of the left ventricular myocardium, dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy. To explore the role of Cypher in myocardium and to better understand molecular mechanisms by which mutations in cypher cause cardiomyopathy, we utilized a conditional approach to knockout Cypher, specially in either developing or adult myocardium. Cardiac-specific Cypher knockout (CKO) mice developed a severe form of DCM with disrupted cardiomyocyte ultrastructure and decreased cardiac function, which eventually led to death before 23 weeks of age. A similar phenotype was observed in inducible cardiac-specific CKO mice in which Cypher was specifically ablated in adult myocardium. In both cardiac-specific CKO models, ERK and Stat3 signaling pathways were augmented. Finally, we demonstrate the specific binding of Cypher's PDZ domain to the C-terminal region of both calsarcin-1 and myotilin within the Z-line. In conclusion, our studies suggest that (i) Cypher plays a pivotal role in maintaining adult cardiac structure and cardiac function through protein-protein interactions with other Z-line proteins, (ii) myocardial ablation of Cypher results in DCM with premature death and (iii) specific signaling pathways participate in Cypher mutant-mediated dysfunction of the heart, and may in concert facilitate the progression to heart failure.

[1]  M. Keating,et al.  Metavinculin Mutations Alter Actin Interaction in Dilated Cardiomyopathy , 2002, Circulation.

[2]  J. Partanen,et al.  Targeted Deletion of the Muscular Dystrophy Gene myotilin Does Not Perturb Muscle Structure or Function in Mice , 2006, Molecular and Cellular Biology.

[3]  J. Seidman,et al.  The Genetic Basis for Cardiomyopathy from Mutation Identification to Mechanistic Paradigms , 2001, Cell.

[4]  K. Pelin,et al.  Identification of 45 novel mutations in the nebulin gene associated with autosomal recessive nemaline myopathy , 2006, Human mutation.

[5]  Qiang Zhou,et al.  Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy , 2001, The Journal of cell biology.

[6]  K. Campbell,et al.  Dystrophin-Glycoprotein Complex: Post-translational Processing and Dystroglycan Function* 210 , 2003, The Journal of Biological Chemistry.

[7]  J. Potter,et al.  Sarcomeric Protein Mutations in Dilated Cardiomyopathy , 2005, Heart Failure Reviews.

[8]  S. Thibodeau,et al.  Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. , 1998, Science.

[9]  Qiang Zhou,et al.  Cypher, a Striated Muscle-restricted PDZ and LIM Domain-containing Protein, Binds to α-Actinin-2 and Protein Kinase C* , 1999, The Journal of Biological Chemistry.

[10]  Jason T. Su,et al.  Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. , 1997, Circulation.

[11]  Andrew G Engel,et al.  Mutations in ZASP define a novel form of muscular dystrophy in humans , 2005, Annals of neurology.

[12]  S. Kempa,et al.  Indications for a Novel Muscular Dystrophy Pathway , 2000, The Journal of cell biology.

[13]  Seth G. N. Grant,et al.  PDZ Domain Proteins: Plug and Play! , 2003, Science's STKE.

[14]  Michael J Ackerman,et al.  Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. , 2006, Biochemical and biophysical research communications.

[15]  Masahiko Hoshijima,et al.  The Cardiac Mechanical Stretch Sensor Machinery Involves a Z Disc Complex that Is Defective in a Subset of Human Dilated Cardiomyopathy , 2002, Cell.

[16]  P. Burch,et al.  Desmin mutation responsible for idiopathic dilated cardiomyopathy. , 1999, Circulation.

[17]  J. Ross,et al.  Transthoracic echocardiography in models of cardiac disease in the mouse. , 1996, Circulation.

[18]  J. Kere,et al.  Myotilin, a novel sarcomeric protein with two Ig-like domains, is encoded by a candidate gene for limb-girdle muscular dystrophy. , 1999, Human molecular genetics.

[19]  M. Okabe,et al.  Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. McNally,et al.  The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. , 2004, Circulation research.

[21]  J. Ross,et al.  Selective Requirement of Myosin Light Chain 2v in Embryonic Heart Function* , 1998, The Journal of Biological Chemistry.

[22]  John Atherton,et al.  Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy , 2002, Nature Genetics.

[23]  M. Bang,et al.  "Z"eroing in on the role of Cypher in striated muscle function, signaling, and human disease. , 2007, Trends in cardiovascular medicine.

[24]  A. Sonnenberg,et al.  The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins , 2005, Journal of Cell Science.

[25]  Chengqun Huang,et al.  Characterization and in Vivo Functional Analysis of Splice Variants of Cypher* , 2003, The Journal of Biological Chemistry.

[26]  H. Watkins,et al.  Alterations in Thin Filament Regulation Induced by a Human Cardiac Troponin T Mutant That Causes Dilated Cardiomyopathy Are Distinct from Those Induced by Troponin T Mutants That Cause Hypertrophic Cardiomyopathy* , 2002, The Journal of Biological Chemistry.

[27]  G. Lanfranchi,et al.  ZASP: a new Z-band alternatively spliced PDZ-motif protein. , 1999, The Journal of cell biology.

[28]  T. Hewett,et al.  Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. , 1996, The Journal of clinical investigation.

[29]  艶琳 Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity , 2006 .

[30]  J. Towbin,et al.  Dilated Cardiomyopathy: A Tale of Cytoskeletal Proteins and Beyond , 2006, Journal of cardiovascular electrophysiology.

[31]  S. Solomon,et al.  Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. , 2001, The New England journal of medicine.

[32]  A. Zima,et al.  Endothelin-1–Induced Arrhythmogenic Ca2+ Signaling Is Abolished in Atrial Myocytes of Inositol-1,4,5-Trisphosphate(IP3)–Receptor Type 2–Deficient Mice , 2005, Circulation research.

[33]  M. Komajda,et al.  Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. , 2005, European heart journal.

[34]  F. Takahashi‐Yanaga,et al.  Ca2+-desensitizing effect of a deletion mutation ΔK210 in cardiac troponin T that causes familial dilated cardiomyopathy , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Sanger,et al.  The Dynamic Z Bands of Striated Muscle Cells , 2008, Science Signaling.

[36]  K. Chien,et al.  Complexity in simplicity: monogenic disorders and complex cardiomyopathies. , 1999, The Journal of clinical investigation.

[37]  J. Seidman,et al.  Severe Heart Failure and Early Mortality in a Double-Mutation Mouse Model of Familial Hypertrophic Cardiomyopathy , 2008, Circulation.

[38]  E. Olson,et al.  Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress , 2004, Nature Medicine.

[39]  Andrew G Engel,et al.  Mutations in myotilin cause myofibrillar myopathy , 2004, Neurology.

[40]  R. Wersto,et al.  Intracellular acidosis‐activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  J. Gilbert,et al.  Myotilin is mutated in limb girdle muscular dystrophy 1A. , 2000, Human molecular genetics.

[42]  E. McNally,et al.  Sarcomere Mutations in Cardiomyopathy, Noncompaction, and the Developing Heart , 2008, Circulation.

[43]  Qiang Zhou,et al.  A Cypher/ZASP Mutation Associated with Dilated Cardiomyopathy Alters the Binding Affinity to Protein Kinase C* , 2004, Journal of Biological Chemistry.

[44]  M. Crackower,et al.  Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein , 2001, Circulation research.

[45]  S. S. Zhang,et al.  Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Lichtenberg,et al.  Alterations in Janus Kinase (JAK)-Signal Transducers and Activators of Transcription (STAT) Signaling in Patients With End-Stage Dilated Cardiomyopathy , 2003, Circulation.

[47]  G. Valle,et al.  Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. , 2003, Journal of the American College of Cardiology.

[48]  M. Barančík,et al.  Mitogen-activated protein kinases: A new therapeutic target in cardiac pathology , 2003, Molecular and Cellular Biochemistry.

[49]  E. Olson,et al.  Calsarcin-3, a Novel Skeletal Muscle-specific Member of the Calsarcin Family, Interacts with Multiple Z-disc Proteins* , 2002, The Journal of Biological Chemistry.

[50]  A. Porras,et al.  A role for p38α mitogen‐activated protein kinase in embryonic cardiac differentiation , 2008, FEBS letters.

[51]  Yibin Wang,et al.  Stress-activated MAP kinases in cardiac remodeling and heart failure; new insights from transgenic studies. , 2004, Trends in cardiovascular medicine.

[52]  F. Bost,et al.  p38 Mitogen‐Activated Protein Kinase Activity Commits Embryonic Stem Cells to Either Neurogenesis or Cardiomyogenesis , 2006, Stem cells.

[53]  R. Solaro,et al.  Multiplex Kinase Signaling Modifies Cardiac Function at the Level of Sarcomeric Proteins* , 2008, Journal of Biological Chemistry.

[54]  M. Saraste,et al.  FEBS Lett , 2000 .